Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

Diabetes Gel Regranex Linked to Cancer

Regranex Users Have 5 Times More Cancer Deaths
WebMD Health News
Reviewed by Louise Chang, MD

June 6, 2008 -- Diabetes patients who use Regranex gel to treat dangerous foot and leg ulcers may have a fivefold higher risk of dying from cancer, the FDA today warned.

The FDA will ask Regranex maker Ethicon (a division of Johnson & Johnson) to put a "black box" warning label on the drug. The black-box warning is FDA's highest warning level.

"In announcing this label change, FDA still cautions health care professionals to carefully weigh the risks and benefits of treating patients with Regranex," Susan Walker, MD, director of the FDA's Division of Dermatological and Dental Products, says in a news release. "Regranex is not recommended for patients with known malignancies."

The cancer finding comes from an FDA review of a postmarketing survey that suggested there might be a link between Regranex and cancer.

"FDA has now completed its review of the study and has concluded that the increase in the risk of death from cancer in patients who used three or more tubes of Regranex was five times higher than in those patients who did not use Regranex," the FDA reports.

Despite this fivefold increase in risk, the finding is based on only four excess cases of cancer, according to an Ethicon news release.

"We remain committed to the safety and efficacy of this product when used according to its label," Ethicon spokeswoman Jackie Jankewicz tells WebMD.

Regranex is a medicine that is a genetically engineered form of a human growth factor that helps wounds heal faster. It is a huge benefit to diabetic patients with slow-healing wounds on their legs or feet that often result in amputation of the affected limb.

Because Regranex makes cells grow faster, there has been concern that it will also make cancer cells grow more quickly. That's why Ethicon has monitored patients since the drug was approved in December 1997.

There's no evidence that Regranex causes new cancers, although the follow-up study has not gone on long enough to rule out this possibility.

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
Home Healthcare

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner